Location History:
- Chicago, IL (US) (2009)
- Charleston, SC (US) (2014 - 2018)
Company Filing History:
3 out of 2,359 
1 out of 832,961 Years Active: 2009-2018
Title: Chenthamarakshan Vasu: Innovator in Diabetes Treatment
Introduction
Chenthamarakshan Vasu is a notable inventor based in Charleston, SC (US). He has made significant contributions to the field of diabetes treatment, holding a total of 4 patents. His work focuses on innovative protein therapies aimed at improving the lives of individuals with type 1 diabetes.
Latest Patents
Among his latest patents is the development of an anti-CTLA4, anti-GLUT2 protein for the treatment of type 1 diabetes. This invention involves a protein composed of a first polypeptide that specifically binds to Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) on T-cell surfaces. Additionally, it includes a second polypeptide that binds to Glucose Transporter 2 (GLUT2) on pancreatic β-cell surfaces. The unique mechanism of this protein induces a CTLA-4 specific agonist response in T-cells while preserving GLUT2 function, ultimately reducing immunoreactivity against pancreatic β-cells.
Career Highlights
Chenthamarakshan Vasu has worked with esteemed institutions, including the University of Illinois. His research and innovations have positioned him as a key figure in the development of therapeutic strategies for diabetes management.
Collaborations
He has collaborated with notable professionals in his field, including Bellur S Prabhakar and Palash Bhattacharya. These partnerships have further enhanced the impact of his research and inventions.
Conclusion
Chenthamarakshan Vasu's contributions to diabetes treatment through his innovative patents highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in therapeutic approaches for type 1 diabetes.